|
First author | Year | Dose | Sample | Duration (w) | Number | Study design | Outcome measure | Results |
|
McVeigh [110] | 1994 | 1800 mg EPA + 1200 mg DHA/d versus placebo (olive oil) | Type 2 diabetes | 6 | 20 | RCT-PC | Total AC | Increase in total AC |
|
Nestel [111] | 2002 | 3000 mg EPA/d versus 3000 mg DHA/d versus placebo (olive oil) | Dyslipidemic | 7 | 38 | RCT-PC | Total AC | Increase 36% with EPA, 27% with DHA |
|
Tomiyama [62] |
2011 | 1800 mg EPA/d versus control (diet therapy) | Dyslipidemic | 52 | 84 | RCT-PG | ba-PWV | Reduction of ba-PWV |
|
Hjerkinn [29] | 2006 | 2400 mg n-3 PUFA versus control diet | Dyslipidemic | 156 | 563 | RCT-PG | cr-PWV | Decrease in cr-PWV 4% |
|
Hill [112] | 2007 | 1560 mg DHA + 360 mg EPA/d versus placebo (6 g sunflower oil/d) | Overweight, hypertensive, dyslipidemic | 6 to 12 | 38 | RCT-PC | Small and large AC | Increase in small AC 26%. |
|
Mita [28] | 2007 | 1800 mg EPA/d versus control (no EPA) | Type 2 diabetes | 6 | 64 | RCT-PG | ba-PWV | Reduction of ba-PWV |
|
Wang [113] | 2008 | 540 mg EPA + 360 mg DHA versus placebo capsules | Overweight, hypertensive | 8 | 52 | RCT-PC | Small and large AC | Increase in large AC 21% |
|
Satoh [114] | 2009 | 1800 mg EPA/d + diet versus control (diet only) | Metabolic syndrome | 12 | 92 | RCT-PG | ca-PWV | Reduction of ca-PWV 6% |
|
Ayer [115] | 2009 | 32 mg EPA/d + 135 mg DHA/d + canola oil versus control diet | Healthy children | 260 | 616 | RCT-PG | Carotid artery distensibility, cb-PWV, Aix | No difference |
|
Sjoberg [116] | 2010 | 1560 DHA + 360 mg EPA/d versus placebo (sunola oil) | Overweight | 12 | 67 | RCT-PC | Small and large AC | Increase in large AC 14% |
|
Dangardt [60] | 2010 | 1200 mg n-3 PUFA versus placebo | Obese adolescents | 12 | 25 | RCT-PC | cf-PWV | No difference |
|
Sanders [58] | 2011 | 1800 mg n-3 PUFA versus placebo | Healthy subjects | 52 | 312 | RCT-PC | cf-PWV | Decrease in cf-PWV |
|
Haiden [57] | 2012 | 1800 mg n-3 PUFA versus placebo | Hypertensive, dyslipidemic | 52 | 19 | CT | ba-PWV, aortic strain rate | Decrease in ba-PWV 1%, strain rate 17% |
|
Siasos [54] | 2013 | 2000 mg n-3 PUFA versus placebo | Healthy smokers | 12 | 20 | RCT-PC | cf-PWV | Decrease in cf-PWV 6% |
|
Root [59] | 2013 | 1700 mg n-3 PUFA versus placebo | Overweight young | 4 | 30 | RCT-PC | cf-PWV | No difference |
|
Wong [56] | 2013 | 4000 mg n-3 PUFA + diet versus diet alone | Obese | 12 | 13 | RCT-PC | Small and large AC | Increase in large AC 20%, small AC 22% |
|
Tousoulis [55] | 2014 | 2000 mg n-3 PUFA versus placebo | Metabolic syndrome | 12 | 29 | RCT-PC | cf-PWV | Decrease in cf-PWV 5% |
|